Interestingly, HE4 levels were notably higher among IPAH patients compared to those of control subjects (6.9 ± 2.2 vs 4.4 ± 0.9 ng/ml, p<0.001, Fig. 1). The gene discussed is WFDC2; the disease is idiopathic pulmonary arterial hypertension.